Nestlé to Use AI & Nutrition Science for Products Aimed at Weight-Loss Drug Users

plans to leverage artificial intelligence and nutritional science to develop specialised products for millions of consumers using weight-loss drugs such as Ozempic and Wegovy. The company is also testing AI-driven consumer simulations to better understand needs related to side effects like muscle loss and nutritional gaps. This initiative aims to turn the rise of GLP-1 medications into a growth opportunity by addressing specific dietary requirements of these users. Top stocks in the FMCG / packaged foods industry: Hindustan Unilever, Britannia Industries, and ITC.